Public Company Healthcare

CooperCompanies

San Ramon, California, United States

CooperCompanies (NASDAQ: COO) is a global medical device company with two business units: CooperVision (contact lenses) and CooperSurgical (fertility and women’s healthcare medical devices, technologies, and services).

Focus Areas
Contact lenses, Fertility and women’s healthcare, Ophthalmic products

Tracked deals

4

4 tracked deals across 2021-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

4 buyout

CooperCompanies Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for CooperCompanies. 3 2021 1 2024

Supporting Data

Recent Transactions

  • CooperSurgical (CooperCompanies) Acquires obp Surgical
    August 1, 2024
    Buyer
    CooperSurgical, CooperCompanies
    Target
    obp Surgical Corporation
    Industry
    Medical Devices
    Location
    Massachusetts, United States
    Type
    Buyout

    CooperCompanies, through its CooperSurgical business, has acquired obp Surgical, a U.S.-based maker of single-use cordless surgical retractors and suction devices, for approximately $100 million. obp Surgical's ONETRAC products generated roughly $14.5 million of trailing twelve-month revenue; Cooper said the acquisition will be neutral to non-GAAP EPS in fiscal 2024 and accretive thereafter and will be reported in its Office and Surgical category.

  • CooperCompanies Acquires Generate Life Sciences
    November 10, 2021
    Buyer
    CooperCompanies
    Target
    Generate Life Sciences
    Seller
    GI Partners
    Industry
    Healthcare Services
    Location
    California, United States
    Type
    Buyout

    CooperCompanies agreed to acquire Generate Life Sciences from GI Partners for approximately $1.6 billion. The deal expands CooperSurgical’s fertility, donor-gamete and newborn stem cell (cord blood & tissue) offerings; Generate reported roughly $250 million in trailing twelve-month revenue and will be integrated into CooperSurgical pending customary closing conditions.

  • CooperCompanies (CooperSurgical) Acquires Safe Obstetric Systems
    March 1, 2021
    Buyer
    CooperCompanies, CooperSurgical
    Target
    Safe Obstetric Systems
    Industry
    Medical Devices
    Location
    United Kingdom
    Type
    Buyout

    CooperCompanies, through its CooperSurgical business unit, acquired Safe Obstetric Systems, the UK-based maker of the FDA‑approved Fetal Pillow used in cesarean deliveries. The deal value is approximately £37.5 million in cash plus up to £10.0 million in contingent payments; Fetal Pillow generated about £3.5 million in revenue in 2020. The acquisition expands CooperSurgical’s women’s health / medical device portfolio and brings the Fetal Pillow into Cooper’s global distribution network.

  • CooperSurgical Acquires AEGEA Medical
    February 2, 2021
    Buyer
    CooperSurgical, CooperCompanies
    Target
    AEGEA Medical
    Industry
    Medical Devices
    Location
    California, United States
    Type
    Buyout

    CooperSurgical, a subsidiary of CooperCompanies, has acquired California-based AEGEA Medical and its FDA-approved Mara Water Vapor Ablation System. The acquisition expands CooperSurgical’s portfolio of in-office women’s health products by adding an endometrial ablation device for treatment of heavy menstrual bleeding.

Related Acquisition Pages

Medical Devices Buyers & Acquisitions 3 tracked deals by CooperCompanies. Healthcare Services Buyers & Acquisitions 1 tracked deal by CooperCompanies. Acquisitions in California 2 tracked deals by CooperCompanies. Acquisitions in Massachusetts 1 tracked deal by CooperCompanies.

Related articles

Selling a company? Get in front of buyers like CooperCompanies

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →